Drug Shortage Report for ZYMAR
Report ID | 33440 |
Drug Identification Number | 02257270 |
Brand name | ZYMAR |
Common or Proper name | ZYMAR 1mL |
Company Name | ABBVIE CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | GATIFLOXACIN |
Strength(s) | 0.3% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC |
Packaging size | 5mL |
ATC code | S01AE |
ATC description | ANTIINFECTIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-09-16 |
Actual start date | 2019-09-16 |
Estimated end date | 2019-09-20 |
Actual end date | 2019-09-18 |
Shortage status | Resolved |
Updated date | 2019-09-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-12-18 | English | Compare |
v2 | 2017-12-18 | English | Compare |
v3 | 2019-09-16 | English | Compare |
v4 | 2019-09-16 | English | Compare |
v5 | 2019-09-16 | English | Compare |
v6 | 2019-09-16 | French | Compare |
v7 | 2019-09-17 | English | Compare |
v8 | 2019-09-18 | English | Compare |
v9 | 2019-09-18 | French | Compare |
v10 | 2019-09-19 | English | Compare |
Showing 1 to 10 of 10